Gilead Oncology Grant Supports 22 U.S. Organizations With $3.15 Million to Provide Support to Those Affected By Breast Cancer

Rhea-AI Summary

Gilead Sciences has announced a $3.15 million grant initiative supporting 22 U.S. organizations focused on providing resources and assistance to individuals affected by breast cancer. The initiative, known as the Gilead Oncology Grant, aims to promote health equity across the cancer care continuum. This funding demonstrates Gilead's commitment to transforming and simplifying care for patients with life-threatening illnesses.

Positive

• Allocated $3.15 million in grants to support breast cancer initiatives
• Expanded healthcare support network through partnerships with 22 organizations

Negative

• None.

Argus Session date unavailable

+0.60% session move Open Argus

Details

News Market Reaction – GILD

The recorded move for GILD in the trading session of this news was +0.60%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTHAMPTON, MA / ACCESSWIRE / October 31, 2024 / Gilead Sciences

We're prioritizing health equity for patients across the cancer care continuum. Our Gilead Oncology Grant supports 22 U.S. organizations with $3.15 million to provide resources for people affected by breast cancer. Learn more here: https://gilead.inc/3NM4Vmo

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com

SOURCE: Gilead Sciences

View the original press release on accesswire.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did Gilead Sciences (GILD) allocate for breast cancer support grants in 2024?

Gilead Sciences allocated $3.15 million in grants to support 22 U.S. organizations providing resources for people affected by breast cancer.

How many organizations received breast cancer support grants from Gilead (GILD) in October 2024?

22 U.S. organizations received grants through the Gilead Oncology Grant program.

What is the purpose of Gilead's (GILD) 2024 Oncology Grant program?

The Gilead Oncology Grant program aims to promote health equity for patients across the cancer care continuum and provide support to those affected by breast cancer.